| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,956,339 | 2,198,237 | 1,901,979 | 1,243,336 | 933,013 |
| Cost of Revenue
|
-845,373 | -839,605 | -319,099 | -150,343 | -139,989 |
|
Gross Profit
|
1,110,966 | 1,358,632 | 1,582,880 | 1,092,993 | 793,024 |
| Selling, General and Administrative Expenses
|
-463,460 | -491,716 | -557,872 | -481,871 | -451,421 |
|
Research and Development Expenses
|
-653,103 | -1,522,066 | -804,522 | -877,387 | -877,090 |
| Depreciation, Amortization and Depletion
|
-2,803 | -2,622 | -2,405 | -1,559 | -714 |
|
Operating Income/Expenses
|
-1,119,366 | -2,016,404 | -1,364,799 | -1,360,817 | -1,329,225 |
|
Total Operating Profit/Loss
|
-8,400 | -657,772 | 218,081 | -267,824 | -536,201 |
| Total Net Finance Income/Expense
|
-52,679 | -1,450 | 53,376 | 63,959 | -25,525 |
|
Amortization and Accretion of Securities
|
-- | -- | -- | -- | 11,235 |
| Net Investment Income
|
-1,329 | -15,914 | -2,785 | 1,527 | -- |
| Irregular Income/Expenses
|
-27,398 | -25,147 | -7,838 | -418,850 | -121,316 |
|
Other Income/Expense, Non-Operating
|
-2,210 | -1,942 | -60 | 101,090 | -6,921 |
|
Non-Operating Income/Expenses, Total
|
-83,616 | -44,453 | 42,693 | -252,274 | -153,762 |
|
Pretax Income
|
-92,016 | -702,225 | 260,774 | -520,098 | -689,963 |
|
Provision for Income Tax
|
-22,602 | -11,185 | -25,535 | -15,879 | -13,525 |
|
Net Income from Continuing Operations
|
-114,618 | -713,410 | 235,239 | -535,977 | -703,488 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-114,618 | -713,410 | 235,239 | -535,977 | -703,488 |
|
Net Income after Non-Controlling/Minority Interests
|
-114,618 | -713,410 | 235,239 | -535,977 | -703,488 |
|
Net Income Available to Common Stockholders
|
-114,618 | -713,410 | 235,239 | -535,977 | -703,488 |
|
Dilution to Earnings
|
1,865 | -- | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
-112,753 | -713,410 | 235,239 | -535,977 | -703,488 |
| Basic EPS
|
-1.11 | -7.13 | 2.47 | -5.80 | -8.03 |
| Diluted EPS
|
-1.15 | -7.13 | 2.34 | -5.80 | -8.03 |
|
Basic Weighted Average Shares Outstanding
|
105,301 | 100,120 | 95,075 | 92,398 | 87,559 |
|
Diluted Weighted Average Shares Outstanding
|
106,945.75 | 100,120 | 107,875 | 92,398 | 87,559 |
|
Reported Normalized Diluted EPS
|
0.34 | -5.05 | 3.69 | -0.64 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-39,337 | -700,775 | 207,398 | -584,057 | -664,438 |
|
EBITDA
|
-7,181 | -656,254 | 245,122 | -539,660 | -622,574 |
12/31/2022 - 8/22/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade